| Modeling human severe combined immunodeficiency and correction by CRISPR/Cas9-enhanced gene targeting CW Chang, YS Lai, E Westin, A Khodadadi-Jamayran, KM Pawlik, ... Cell reports 12 (10), 1668-1677, 2015 | 136 | 2015 |
| Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts ER Westin, E Chavez, KM Lee, FA Gourronc, S Riley, PM Lansdorp, ... Aging cell 6 (3), 383-394, 2007 | 75 | 2007 |
| The p53/p21WAF/CIP pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency ER Westin, N Aykin-Burns, EM Buckingham, DR Spitz, FD Goldman, ... Antioxidants & redox signaling 14 (6), 985-997, 2011 | 63 | 2011 |
| Novel HDAd/EBV reprogramming vector and highly efficient Ad/CRISPR-Cas sickle cell disease gene correction C Li, L Ding, CW Sun, LC Wu, D Zhou, KM Pawlik, ... Scientific reports 6 (1), 30422, 2016 | 47 | 2016 |
| DNA damage responses and oxidative stress in dyskeratosis congenita L Pereboeva, E Westin, T Patel, I Flaniken, L Lamb, A Klingelhutz, ... PloS one 8 (10), e76473, 2013 | 46 | 2013 |
| Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART−/− IL2RG−/Y SCID Pigs AN Boettcher, Y Li, AP Ahrens, M Kiupel, KA Byrne, CL Loving, ... Frontiers in Immunology 11, 100, 2020 | 25 | 2020 |
| Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells L Pereboeva, M Hubbard, FD Goldman, ER Westin PLoS One 11 (2), e0148793, 2016 | 17 | 2016 |
| Systematic screening for subtelomeric anomalies in a clinical sample of autism TH Wassink, M Losh, J Piven, VC Sheffield, E Ashley, ER Westin, SR Patil Journal of autism and developmental disorders 37, 703-708, 2007 | 14 | 2007 |
| Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts C Sorge, L Pereboeva, E Westin, WT Harris, DR Kelly, F Goldman Bone Marrow Transplantation 52 (5), 765-768, 2017 | 12 | 2017 |
| Validation of single-gene noninvasive prenatal testing for sickle cell disease ER Westin, DS Tsao, O Atay, BP Landry, PY Patrick, DC Brown, B Alford, ... American journal of hematology 97 (7), E270, 2022 | 7 | 2022 |
| Bone marrow transplantation after nonmyeloablative treosulfan conditioning is curative in a murine model of sickle cell disease D Devadasan, CW Sun, ER Westin, LC Wu, KM Pawlik, TM Townes, ... Biology of Blood and Marrow Transplantation 24 (8), 1554-1562, 2018 | 3 | 2018 |
| Generation of inducible pluripotent stem cell lines from Alzheimer’s disease patients with APOE e3/e3 genotype J Lee, Z Liu, YG Tusing, C Li, E Westin, W Li, R Zhao Stem cell research 55, 102498, 2021 | 2 | 2021 |
| Consistent Upregulation of Oxidative Stress and DNA Damage Amongst Dyskeratosis Congenita Genotypes: Ameliorative Effects of Antioxidants L Pereboeva, E Westin, M Hubbard, FD Goldman Blood 124 (21), 1603, 2014 | 2 | 2014 |
| Clinical validity of single-gene non-invasive prenatal testing for sickle cell disease and beta thalassemia ER Westin, DS Tsao, O Atay, BP Landry, PP Ye, D Chandler-Brown, ... medRxiv, 2021.09. 02.21262837, 2021 | 1 | 2021 |
| Crispr Modification of Induced Pluripotent Stem Derived from Diamond-Blackfan Anemia Fibroblasts E Westin, D Devadasan, C Li, L Ding, TM Townes, FD Goldman Blood 124 (21), 4804, 2014 | 1 | 2014 |
| # StemCells: Education, Innovation, and Outreach BG Bruneau, P Tesar, SL Solomon, PS Knoepfler, E Westin, BM Ellison, ... Cell Stem Cell 13 (5), 517-519, 2013 | 1 | 2013 |
| CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response ER Westin, A Khodadadi-Jamayran, LK Pham, ML Tung, FD Goldman G3: Genes, Genomes, Genetics 13 (11), jkad207, 2023 | | 2023 |
| Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system D Wallis, C Fay, K Bradley, E Westin, W Bradley, H Liu, D Crossman, ... Cancer Research 83 (7_Supplement), 1726-1726, 2023 | | 2023 |
| Abstract P3-08-01: Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system D Wallis, C Fay, K Bradley, E Westin, W Bradley, H Liu, L Lambert, ... Cancer Research 83 (5_Supplement), P3-08-01-P3-08-01, 2023 | | 2023 |
| NF1 Gene Rescue via Nanoparticles Decreases Mammary Tumor Burden in NF1-Knockout Rats L Lambert, ER Westin, K Bradley, M Chen, S Urban, M Newton, D Wallis, ... MOLECULAR THERAPY 30 (4), 166-166, 2022 | | 2022 |
